---
title: "Insider Confidence Surges as Tivic Health Systems Director Doubles Down"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281595239.md"
description: "Insider activity at Tivic Health Systems (TIVC) saw Director Valauri Christina Rizopoulos purchase 19,000 shares, valued at $17,860, indicating strong insider confidence. However, TIVC shares are under pressure due to Nasdaq's sub-$1 bid price, reflecting weak financials and bearish sentiment. Analysts are reassessing the company's long-term prospects as it pivots to its Entolimod TLR5 platform and engages in government discussions. TipRanks’ AI Analyst rates TIVC as Neutral, citing weak financial performance and high risk despite some liquidity improvements."
datetime: "2026-04-03T02:05:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281595239.md)
  - [en](https://longbridge.com/en/news/281595239.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281595239.md)
---

# Insider Confidence Surges as Tivic Health Systems Director Doubles Down

New insider activity at Tivic Health Systems ( (TIVC) ) has taken place on April 2, 2026.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Director Valauri Christina Rizopoulos has increased her stake in Tivic Health Systems by purchasing 19,000 shares of the company’s stock, in a transaction valued at $17,860, signaling a notable insider commitment to the firm.

**Recent Updates on TIVC stock**

Tivic Health Systems’ shares remain pressured as Nasdaq flagged its sub‑$1 bid price, reflecting weak financials, cash burn, and bearish technicals that weigh on sentiment and valuation models. At the same time, analysts are reassessing long‑term prospects as the company pivots to its Entolimod TLR5 platform, secures NIAID‑funded GI‑ARS studies, and advances government stockpiling discussions, which could improve funding visibility and de‑risk development if converted into contracts.

**Spark’s Take on TIVC Stock**

According to Spark, TipRanks’ AI Analyst, TIVC is a Neutral.

The score is constrained primarily by weak financial performance (shrinking revenue base, large operating losses, cash burn, and balance-sheet erosion) and a bearish technical setup with the stock below major moving averages. The earnings call provides partial offset due to progress on the biopharma pivot and some liquidity improvement, but losses, delays, and an unhelpful negative P/E keep the overall risk high.

To see Spark’s full report on TIVC stock, click here.

**More about Tivic Health Systems**

**YTD Price Performance:** -30.34%

**Average Trading Volume:** 228,662

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $2.91M

### Related Stocks

- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [TIVC.US](https://longbridge.com/en/quote/TIVC.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)

## Related News & Research

- [Major Onconetix Investor Makes Bold Move With Fresh Buy and Large Share Unload](https://longbridge.com/en/news/283590854.md)
- [Thermo Fisher Scientific: Buy Rating Reiterated on Solid Core Growth and Emerging AI, Reshoring Catalysts](https://longbridge.com/en/news/283833996.md)
- [GE HealthCare (GEHC) Q1 Earnings Report Preview: What To Look For](https://longbridge.com/en/news/284303783.md)
- [Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings](https://longbridge.com/en/news/283839392.md)
- [Top Wall Street Forecasters Revamp Boston Scientific Expectations Ahead Of Q1 Earnings](https://longbridge.com/en/news/283616477.md)